Results 161 to 170 of about 21,878 (196)
ACO-SWITCH: Rationale and Design of a Phase 4 Study Evaluating Serum Transthyretin in ATTR-CM After Switching from Tafamidis to Acoramidis. [PDF]
Cardiol TherPfister R +6 more
europepmc +1 more source
A Genetic Polymorphism in RBP4 Is Associated with Coronary Artery Disease [PDF]
International Journal of Molecular Sciences, 2014 Insulin resistance and obesity is influenced by the retinol binding protein 4 (RBP4) adipokine. This study aims to determine if genetic polymorphisms in RBP4 are associated with the risk of coronary artery disease (CAD) in Chinese patients. RBP4 polymorphisms were analyzed by high resolution melting (HRM) analysis in a case-control study of 392 ...
Yucheng Chen, Ying Deng
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Clinical Lipidology, 2019
The regulation of adipose tissue metabolism in early childhood obesity is not well understood. Insulin levels are higher and insulin resistance seems to be present in prepubertal children with obesity but, differing from their behavior in adults with obesity, non-esterified fatty acid (NEFA) concentrations are not increased.
Henar Ortega-Senovilla +2 more
openaire +2 more sources
The regulation of adipose tissue metabolism in early childhood obesity is not well understood. Insulin levels are higher and insulin resistance seems to be present in prepubertal children with obesity but, differing from their behavior in adults with obesity, non-esterified fatty acid (NEFA) concentrations are not increased.
Henar Ortega-Senovilla +2 more
openaire +2 more sources
Nature Medicine, 2006
Defects in the ability of fat cells to transport glucose are linked to insulin resistance in muscle and liver. Retinol binding protein 4 (RBP4) now comes to the fore as a new adipokine, linking glucose uptake in adipocytes with systemic insulin sensitivity.
Yoshikazu Tamori +2 more
openaire +1 more source
Defects in the ability of fat cells to transport glucose are linked to insulin resistance in muscle and liver. Retinol binding protein 4 (RBP4) now comes to the fore as a new adipokine, linking glucose uptake in adipocytes with systemic insulin sensitivity.
Yoshikazu Tamori +2 more
openaire +1 more source
Stem Cell Reports, 2017 Summary: The transmembrane protein, STRA6, functions as a vitamin A transporter and a cytokine receptor when activated by vitamin A-bound serum retinol binding protein 4 (RBP4).
Liraz Levi, Matthew F Kalady, Noa Noy
exaly +2 more sources
Diabetic Medicine, 2008
AbstractAims Retinol binding protein 4 (RBP4) is a newly discovered adipokine, which plays a role in insulin resistance and obesity. The aim of this study was to determine the relationship between genetic variants of the RBP4 gene, circulating RBP4 concentrations and phenotypes related to glucose and lipid metabolism in the Chinese population.Methods
C, Hu +8 more
openaire +2 more sources
AbstractAims Retinol binding protein 4 (RBP4) is a newly discovered adipokine, which plays a role in insulin resistance and obesity. The aim of this study was to determine the relationship between genetic variants of the RBP4 gene, circulating RBP4 concentrations and phenotypes related to glucose and lipid metabolism in the Chinese population.Methods
C, Hu +8 more
openaire +2 more sources
Serum RBP4 and CKD: Association with insulin resistance and lipids
Journal of Diabetes and Its Complications, 2017Serum RBP4 is new adipokine and it has been related to insulin resistance and diabetes risk in animal and clinical studies. However, there is controversy on this relationship among CKD patients. In this study, we evaluated the association of serum RBP4 with insulin resistance and cardiovascular risk factors in CKD.Baseline data from the PROGREDIR Study
Marcia Silva Queiroz +2 more
exaly +3 more sources
Association of RBP4 gene variants with adverse lipid profile and obesity
Gene, 2015Obesity is currently a worldwide public health problem. Retinol-binding protein4 (RBP4) is a recently discovered adipokine, which is potentially associated with insulin resistance and obesity. We aimed to investigate whether genetic variation within the RBP4 gene is correlated with the obesity and lipid profile in Iranian population.
Mansour, Shajarian +4 more
openaire +2 more sources
RBP4 functions as an antagonistic ligand of orphan DR6
Summary Death receptor (DR) is a unique transmembrane receptor mediating extrinsic factor-induced programmed cell death pathways. For most DRs, the regulatory mechanism has been revealed to involve agonistic death ligand (e.g., TRAIL, TNF-α)-driven receptor clustering and activation, offering an in-depth understandingTaeyun Kim +8 more
openaire +1 more source